Video Summary
In April 2025, the US Food and Drug Administration (FDA) announced their plan to phase out animal testing and instead favour more effective, human-relevant methods – namely “New Approach Methodologies” (NAMs).
In our latest Q&A interview, Dr Rebbecca Wilcox, Principal Consultant at Scendea, provides several key insights into what this means for drug developers...